Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes

Kerry A. McLaughlin, Carolyn C. Richardson, Aarthi Ravishankar, Cristina Brigatti, Daniela Liberati, Vito Lampasona, Lorenzo Piemonti, Diana Morgan, Richard G. Feltbower, Michael R. Christie

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The presence of autoantibodies to multiple-islet autoantigens confers high risk for the development of type 1 diabetes. Four major autoantigens are established (insulin, glutamate decarboxylase, IA2, and zinc transporter-8), but the molecular identity of a fifth, a 38-kDa membrane glycoprotein (Glima), is unknown. Glima antibodies have been detectable only by immunoprecipitation from extracts of radiolabeled islet or neuronal cells. We sought to identify Glima to enable efficient assay of these autoantibodies. Mouse brain and lung were shown to express Glima. Membrane glycoproteins from extracts of these organs were enriched by detergent phase separation, lectin affinity chromatography, and SDS-PAGE. Proteins were also immunoaffinity purified from brain extracts using autoantibodies from the sera of patients with diabetes before SDS-PAGE. Eluates from gel regions equivalent to 38 kDa were analyzed by liquid chromatography-tandem mass spectrometry for protein identification. Three proteins were detected in samples from the brain and lung extracts, and in the immunoaffinity-purified sample, but not in the negative control. Only tetraspanin-7, a multipass transmembrane glycoprotein with neuroendocrine expression, had physical characteristics expected of Glima. Tetraspanin-7 was confirmed as an autoantigen by demonstrating binding to autoantibodies in type 1 diabetes. We identify tetraspanin-7 as a target of autoimmunity in diabetes, allowing its exploitation for diabetes prediction and immunotherapy.

Original languageEnglish
Pages (from-to)1690-1698
Number of pages9
JournalDiabetes
Volume65
Issue number6
DOIs
Publication statusPublished - Jun 1 2016

Fingerprint

Type 1 Diabetes Mellitus
Autoantibodies
Autoantigens
Membrane Glycoproteins
Polyacrylamide Gel Electrophoresis
Brain
Lung
Proteins
Glutamate Decarboxylase
Tandem Mass Spectrometry
Autoimmunity
Affinity Chromatography
Immunoprecipitation
Lectins
Liquid Chromatography
Detergents
Immunotherapy
Glycoproteins
Gels
Insulin

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

McLaughlin, K. A., Richardson, C. C., Ravishankar, A., Brigatti, C., Liberati, D., Lampasona, V., ... Christie, M. R. (2016). Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes. Diabetes, 65(6), 1690-1698. https://doi.org/10.2337/db15-1058

Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes. / McLaughlin, Kerry A.; Richardson, Carolyn C.; Ravishankar, Aarthi; Brigatti, Cristina; Liberati, Daniela; Lampasona, Vito; Piemonti, Lorenzo; Morgan, Diana; Feltbower, Richard G.; Christie, Michael R.

In: Diabetes, Vol. 65, No. 6, 01.06.2016, p. 1690-1698.

Research output: Contribution to journalArticle

McLaughlin, KA, Richardson, CC, Ravishankar, A, Brigatti, C, Liberati, D, Lampasona, V, Piemonti, L, Morgan, D, Feltbower, RG & Christie, MR 2016, 'Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes', Diabetes, vol. 65, no. 6, pp. 1690-1698. https://doi.org/10.2337/db15-1058
McLaughlin, Kerry A. ; Richardson, Carolyn C. ; Ravishankar, Aarthi ; Brigatti, Cristina ; Liberati, Daniela ; Lampasona, Vito ; Piemonti, Lorenzo ; Morgan, Diana ; Feltbower, Richard G. ; Christie, Michael R. / Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes. In: Diabetes. 2016 ; Vol. 65, No. 6. pp. 1690-1698.
@article{c51be2fe2887495eac80f00c8179ddb4,
title = "Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes",
abstract = "The presence of autoantibodies to multiple-islet autoantigens confers high risk for the development of type 1 diabetes. Four major autoantigens are established (insulin, glutamate decarboxylase, IA2, and zinc transporter-8), but the molecular identity of a fifth, a 38-kDa membrane glycoprotein (Glima), is unknown. Glima antibodies have been detectable only by immunoprecipitation from extracts of radiolabeled islet or neuronal cells. We sought to identify Glima to enable efficient assay of these autoantibodies. Mouse brain and lung were shown to express Glima. Membrane glycoproteins from extracts of these organs were enriched by detergent phase separation, lectin affinity chromatography, and SDS-PAGE. Proteins were also immunoaffinity purified from brain extracts using autoantibodies from the sera of patients with diabetes before SDS-PAGE. Eluates from gel regions equivalent to 38 kDa were analyzed by liquid chromatography-tandem mass spectrometry for protein identification. Three proteins were detected in samples from the brain and lung extracts, and in the immunoaffinity-purified sample, but not in the negative control. Only tetraspanin-7, a multipass transmembrane glycoprotein with neuroendocrine expression, had physical characteristics expected of Glima. Tetraspanin-7 was confirmed as an autoantigen by demonstrating binding to autoantibodies in type 1 diabetes. We identify tetraspanin-7 as a target of autoimmunity in diabetes, allowing its exploitation for diabetes prediction and immunotherapy.",
author = "McLaughlin, {Kerry A.} and Richardson, {Carolyn C.} and Aarthi Ravishankar and Cristina Brigatti and Daniela Liberati and Vito Lampasona and Lorenzo Piemonti and Diana Morgan and Feltbower, {Richard G.} and Christie, {Michael R.}",
year = "2016",
month = "6",
day = "1",
doi = "10.2337/db15-1058",
language = "English",
volume = "65",
pages = "1690--1698",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "6",

}

TY - JOUR

T1 - Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes

AU - McLaughlin, Kerry A.

AU - Richardson, Carolyn C.

AU - Ravishankar, Aarthi

AU - Brigatti, Cristina

AU - Liberati, Daniela

AU - Lampasona, Vito

AU - Piemonti, Lorenzo

AU - Morgan, Diana

AU - Feltbower, Richard G.

AU - Christie, Michael R.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - The presence of autoantibodies to multiple-islet autoantigens confers high risk for the development of type 1 diabetes. Four major autoantigens are established (insulin, glutamate decarboxylase, IA2, and zinc transporter-8), but the molecular identity of a fifth, a 38-kDa membrane glycoprotein (Glima), is unknown. Glima antibodies have been detectable only by immunoprecipitation from extracts of radiolabeled islet or neuronal cells. We sought to identify Glima to enable efficient assay of these autoantibodies. Mouse brain and lung were shown to express Glima. Membrane glycoproteins from extracts of these organs were enriched by detergent phase separation, lectin affinity chromatography, and SDS-PAGE. Proteins were also immunoaffinity purified from brain extracts using autoantibodies from the sera of patients with diabetes before SDS-PAGE. Eluates from gel regions equivalent to 38 kDa were analyzed by liquid chromatography-tandem mass spectrometry for protein identification. Three proteins were detected in samples from the brain and lung extracts, and in the immunoaffinity-purified sample, but not in the negative control. Only tetraspanin-7, a multipass transmembrane glycoprotein with neuroendocrine expression, had physical characteristics expected of Glima. Tetraspanin-7 was confirmed as an autoantigen by demonstrating binding to autoantibodies in type 1 diabetes. We identify tetraspanin-7 as a target of autoimmunity in diabetes, allowing its exploitation for diabetes prediction and immunotherapy.

AB - The presence of autoantibodies to multiple-islet autoantigens confers high risk for the development of type 1 diabetes. Four major autoantigens are established (insulin, glutamate decarboxylase, IA2, and zinc transporter-8), but the molecular identity of a fifth, a 38-kDa membrane glycoprotein (Glima), is unknown. Glima antibodies have been detectable only by immunoprecipitation from extracts of radiolabeled islet or neuronal cells. We sought to identify Glima to enable efficient assay of these autoantibodies. Mouse brain and lung were shown to express Glima. Membrane glycoproteins from extracts of these organs were enriched by detergent phase separation, lectin affinity chromatography, and SDS-PAGE. Proteins were also immunoaffinity purified from brain extracts using autoantibodies from the sera of patients with diabetes before SDS-PAGE. Eluates from gel regions equivalent to 38 kDa were analyzed by liquid chromatography-tandem mass spectrometry for protein identification. Three proteins were detected in samples from the brain and lung extracts, and in the immunoaffinity-purified sample, but not in the negative control. Only tetraspanin-7, a multipass transmembrane glycoprotein with neuroendocrine expression, had physical characteristics expected of Glima. Tetraspanin-7 was confirmed as an autoantigen by demonstrating binding to autoantibodies in type 1 diabetes. We identify tetraspanin-7 as a target of autoimmunity in diabetes, allowing its exploitation for diabetes prediction and immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=84969821689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969821689&partnerID=8YFLogxK

U2 - 10.2337/db15-1058

DO - 10.2337/db15-1058

M3 - Article

VL - 65

SP - 1690

EP - 1698

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 6

ER -